Swiss National Bank - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 129 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$778,000
-38.8%
356,900
+5.3%
0.00%
-100.0%
Q2 2021$1,271,000
+18.3%
338,900
+2.9%
0.00%0.0%
Q1 2021$1,074,000
-4.4%
329,5000.0%0.00%0.0%
Q4 2020$1,124,000
-12.0%
329,500
+5.2%
0.00%0.0%
Q3 2020$1,277,000
+49.4%
313,100
+23.8%
0.00%0.0%
Q2 2020$855,000
+88.7%
252,900
+30.1%
0.00%
Q1 2020$453,000
-36.0%
194,4000.0%0.00%
-100.0%
Q4 2019$708,000
-54.9%
194,400
+2.8%
0.00%
-50.0%
Q3 2019$1,569,000
-2.0%
189,100
+1.7%
0.00%0.0%
Q2 2019$1,601,000
-14.6%
186,000
+6.0%
0.00%0.0%
Q1 2019$1,875,000
+27.1%
175,400
+4.0%
0.00%0.0%
Q4 2018$1,475,000
-46.3%
168,600
+3.2%
0.00%
-33.3%
Q3 2018$2,745,000
-16.9%
163,400
+3.6%
0.00%
-25.0%
Q2 2018$3,305,000
+17.3%
157,700
-9.9%
0.00%
+33.3%
Q1 2018$2,817,000
+3.2%
175,100
+21.6%
0.00%0.0%
Q4 2017$2,729,000
+44.5%
144,000
+7.3%
0.00%
+50.0%
Q3 2017$1,888,000
+88.8%
134,2000.0%0.00%
+100.0%
Q2 2017$1,000,000
+29.5%
134,200
+13.0%
0.00%0.0%
Q1 2017$772,000
+46.8%
118,8000.0%0.00%0.0%
Q4 2016$526,000
-5.2%
118,8000.0%0.00%0.0%
Q3 2016$555,000
-28.9%
118,8000.0%0.00%0.0%
Q2 2016$781,000
+10.2%
118,800
+3.1%
0.00%0.0%
Q1 2016$709,000
+24.0%
115,200
+21.5%
0.00%0.0%
Q4 2015$572,000
+0.9%
94,8000.0%0.00%0.0%
Q3 2015$567,000
+0.5%
94,800
+14.9%
0.00%0.0%
Q2 2015$564,000
+17.7%
82,500
+4.6%
0.00%0.0%
Q1 2015$479,000
-12.4%
78,9000.0%0.00%
-50.0%
Q4 2014$547,000
-14.8%
78,9000.0%0.00%0.0%
Q3 2014$642,000
+0.2%
78,9000.0%0.00%0.0%
Q2 2014$641,000
+3.6%
78,9000.0%0.00%0.0%
Q1 2014$619,000
+11.5%
78,900
+25.8%
0.00%0.0%
Q4 2013$555,000
+9.5%
62,700
+3.8%
0.00%0.0%
Q3 2013$507,000
+6.5%
60,400
-5.3%
0.00%0.0%
Q2 2013$476,00063,8000.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders